Mental disorders frequently begin in childhood or adolescence. Psychotropic medications
have various indications for the treatment of mental disorders in this age group and are used …

Top‐tier evidence on the safety/tolerability of 80 medications in children/adolescents with
mental disorders has recently been reviewed in this journal. To guide clinical practice, such …

Objectives To use the latest data to estimate the prevalence and correlates of currently
diagnosed depression, anxiety problems, and behavioral or conduct problems among …

Anxiety disorders are among the most common psychiatric disorders in children and
adolescents. As reviewed in this guideline, both cognitive-behavioral therapy (CBT) and …

Introduction: Generalized anxiety disorder (GAD) often begins during adolescence or early
adulthood and persists throughout the lifespan. Randomized controlled trials support the …

Cognitive behavior therapy (CBT) is the most empirically supported therapy for childhood
anxiety disorders (CADs) but has not reliably outperformed other credible interventions. The …

Background Previous Cochrane Reviews have shown that cognitive behavioural therapy
(CBT) is effective in treating childhood anxiety disorders. However, questions remain …

Despite significant advancements in our knowledge of anxiety disorders in children and
adolescents, they continue to be underrecognised and undertreated. It is critical that these …

It is common to measure continuous outcomes using different scales (eg, quality of life,
severity of anxiety or depression), therefore these outcomes need to be standardized before …

The new coronavirus has been present for two years and has had a widespread and
sustained impact worldwide. There is growing evidence in the literature that COVID-19 may …